Table 2.
The expressions of nCD64 and mHLA-DR of the HCs and KTRs.
| Parameters | All cases (n = 141) | HCs (n = 26) | KTRs | P value# | ||
|---|---|---|---|---|---|---|
| Stable KTRs (n = 65) | Infection KTRs (n = 50) | P value* | ||||
| MESF of nCD64 | 4344.50 ± 6372.37 | 1192.58 ± 537.61 | 1697.89 ± 1056.32 | 9424.08 ± 8574.58 | < 0.001 | < 0.001 |
| MESF of mHLA-DR | 2596.92 ± 1054.52 | 2341.27 ± 781.75 | 2728.62 ± 854.87 | 2558.66 ± 1360.77 | 0.392 | 0.273 |
| CD64 Index | 41.58 ± 57.36 | 11.63 ± 4.97 | 17.60 ± 12.03 | 88.33 ± 75.69 | < 0.001 | < 0.001 |
| SI | 213.91 ± 417.41 | 58.86 ± 35.74 | 64.50 ± 32.69 | 488.76 ± 613.43 | < 0.001 | < 0.001 |
*Comparison between the stable KTRs and the infection KTRs.
#Comparison among the three groups.
Tested by the least significant difference test for back testing of multivariate ANOVA.
HCs, Healthy controls; KTRs, kidney transplant recipients, nCD64, neutrophil CD64; mHLA-DR, monocyte HLA-DR; MESF, molecules of equivalent soluble fluorochrome; SI, sepsis index.